FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896490330> ?p ?o ?g. }

• W2896490330 endingPage "112" @default.
• W2896490330 startingPage "98" @default.
• W2896490330 abstract "This systematic review and meta-analysis aimed to update and give an overview of the evidence from published literature that focused on the efficacy of cognitive behaviour therapy (CBT) in the management of somatoform disorders and medically unexplained physical symptoms (MUPS). A comprehensive literature search was carried out through an electronic search of various databases on randomized controlled trials (RCTs). Primary outcome was the severity of somatic symptoms. Secondary outcomes were also measured based on severity of anxiety symptoms, severity of depressive symptoms, social functioning, physical functioning, doctor visits and the compliance with CBT, as well as follow-up visits. Effects were summarized by a random effects model using mean differences or odds ratio with 95% confidence intervals (CIs). A total of 15 RCTs comprising 1671 patients with somatoform disorders or MUPS were enrolled in our systematic review and meta-analysis. The main analysis revealed that CBT could alleviate somatic symptoms: −1.31 (95% CI: −2.23 to −0.39, p = 0.005); anxiety symptoms: -1.89 (95% CI: −2.91 to −0.86; p < 0.001); depressive symptoms: −1.93 (95% CI: −3.56 to −0.31; p = 0.020); improve physical functioning: 4.19 (95% CI: 1.90 to 6.49; p < 0.001). The efficacy of CBT on alleviating somatic symptoms, anxiety and depressive symptoms were sustained on follow-up. CBT may not be effective in reducing the number of doctor visits: −1.23 (95% CI: −2.97 to 0.51; p = 0.166); and improving social functioning: 3.27 (95% CI: −0.08 to 6.63; p = 0.056). The results of subgroup analysis indicated that CBT was particularly beneficial when the duration of session was more than 50 min to reduce the severity of somatic symptoms from pre to post treatment time, when it was group based and applied affective and developed good interpersonal strategy during the treatment. Longer duration and frequency such as more than 10 sessions and 12 weeks treatments had significant effect on reduction of the comorbid symptoms including depression and anxiety, but they may underpin low level of compliance of CBT based treatments. CBT is effective for the treatment of somatoform disorders and MUPS by reducing physical symptoms, psychological distress and disability." @default.
• W2896490330 created "2018-10-26" @default.
• W2896490330 creator A5006202067 @default.
• W2896490330 creator A5016748680 @default.
• W2896490330 creator A5025495036 @default.
• W2896490330 creator A5075000375 @default.
• W2896490330 creator A5080951853 @default.
• W2896490330 date "2019-02-01" @default.
• W2896490330 modified "2023-09-29" @default.
• W2896490330 title "The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: A meta-analysis of randomized controlled trials" @default.
• W2896490330 cites W1660053632 @default.
• W2896490330 cites W1762141714 @default.
• W2896490330 cites W1959338949 @default.
• W2896490330 cites W1966265511 @default.
• W2896490330 cites W1968000474 @default.
• W2896490330 cites W1968125439 @default.
• W2896490330 cites W1977249692 @default.
• W2896490330 cites W1986905167 @default.
• W2896490330 cites W1987776661 @default.
• W2896490330 cites W1990681181 @default.
• W2896490330 cites W1995803107 @default.
• W2896490330 cites W2000875851 @default.
• W2896490330 cites W2004606740 @default.
• W2896490330 cites W2016616105 @default.
• W2896490330 cites W2031078477 @default.
• W2896490330 cites W2036735145 @default.
• W2896490330 cites W2038590224 @default.
• W2896490330 cites W2044541399 @default.
• W2896490330 cites W2045023168 @default.
• W2896490330 cites W2052307185 @default.
• W2896490330 cites W2065034980 @default.
• W2896490330 cites W2065862867 @default.
• W2896490330 cites W2073047577 @default.
• W2896490330 cites W2078155473 @default.
• W2896490330 cites W2085361773 @default.
• W2896490330 cites W2094444069 @default.
• W2896490330 cites W2095986335 @default.
• W2896490330 cites W2097472984 @default.
• W2896490330 cites W2098872361 @default.
• W2896490330 cites W2108532513 @default.
• W2896490330 cites W2110888434 @default.
• W2896490330 cites W2124127816 @default.
• W2896490330 cites W2127465815 @default.
• W2896490330 cites W2128309331 @default.
• W2896490330 cites W2134599421 @default.
• W2896490330 cites W2138752739 @default.
• W2896490330 cites W2140349357 @default.
• W2896490330 cites W2144269887 @default.
• W2896490330 cites W2145040373 @default.
• W2896490330 cites W2146634986 @default.
• W2896490330 cites W2148256510 @default.
• W2896490330 cites W2160493942 @default.
• W2896490330 cites W2165298638 @default.
• W2896490330 cites W2170876802 @default.
• W2896490330 cites W2172497128 @default.
• W2896490330 cites W2494313366 @default.
• W2896490330 cites W2554099036 @default.
• W2896490330 cites W2572767531 @default.
• W2896490330 cites W2740368806 @default.
• W2896490330 cites W2802357213 @default.
• W2896490330 cites W41320383 @default.
• W2896490330 cites W4244813130 @default.
• W2896490330 doi "https://doi.org/10.1016/j.jad.2018.10.114" @default.
• W2896490330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30368076" @default.
• W2896490330 hasPublicationYear "2019" @default.
• W2896490330 type Work @default.
• W2896490330 sameAs 2896490330 @default.
• W2896490330 citedByCount "62" @default.
• W2896490330 countsByYear W28964903302018 @default.
• W2896490330 countsByYear W28964903302019 @default.
• W2896490330 countsByYear W28964903302020 @default.
• W2896490330 countsByYear W28964903302021 @default.
• W2896490330 countsByYear W28964903302022 @default.
• W2896490330 countsByYear W28964903302023 @default.
• W2896490330 crossrefType "journal-article" @default.
• W2896490330 hasAuthorship W2896490330A5006202067 @default.
• W2896490330 hasAuthorship W2896490330A5016748680 @default.
• W2896490330 hasAuthorship W2896490330A5025495036 @default.
• W2896490330 hasAuthorship W2896490330A5075000375 @default.
• W2896490330 hasAuthorship W2896490330A5080951853 @default.
• W2896490330 hasBestOaLocation W28964903302 @default.
• W2896490330 hasConcept C118552586 @default.
• W2896490330 hasConcept C126322002 @default.
• W2896490330 hasConcept C156957248 @default.
• W2896490330 hasConcept C168563851 @default.
• W2896490330 hasConcept C1862650 @default.
• W2896490330 hasConcept C2781265626 @default.
• W2896490330 hasConcept C44249647 @default.
• W2896490330 hasConcept C558461103 @default.
• W2896490330 hasConcept C70410870 @default.
• W2896490330 hasConcept C71924100 @default.
• W2896490330 hasConcept C95190672 @default.
• W2896490330 hasConceptScore W2896490330C118552586 @default.
• W2896490330 hasConceptScore W2896490330C126322002 @default.
• W2896490330 hasConceptScore W2896490330C156957248 @default.
• W2896490330 hasConceptScore W2896490330C168563851 @default.
• W2896490330 hasConceptScore W2896490330C1862650 @default.
• W2896490330 hasConceptScore W2896490330C2781265626 @default.

• next